机译:Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
Department of Investigational Cancer Therapeutics Division of Cancer Medicine The University of;
Department of Internal Medicine Centre for Integrated Oncology University Hospital Cologne;
Division of Medical Oncology Department of Internal Medicine Ohio State University ComprehensiveDepartment of Medicine University of CaliforniaDepartment of Medical Oncology Virginia Cancer Specialists US Oncology ResearchDivision of Oncology Lineberger Comprehensive Cancer Center University of North Carolina Chapel HillDepartment of Medical Oncology Kindai University HospitalDepartment of Thoracic Oncology National Cancer Centre HospitalDepartment of Medical Oncology University of Texas Southwestern Medical CenterDepartment of Respiratory Medicine Okayama University HospitalEli Lilly and CompanyEli Lilly PolskaDepartment of Medicine Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College;